Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
PI3K delta Inhibition Augments the Efficacy of mTOR Inhibitor Rapamycin on the Proliferation of Epstein-Barr Virus (EBV) plus B Cell Lymphomas. 13th American Transplant Congress (ATC) Furukawa, S., Hatton, O., Krams, S., Esquivel, C., Martinez, O. WILEY-BLACKWELL. 2013: 96–97
View details for Web of Science ID 000318240300216